Clinical Trial Technology Provider Reify Raises $220 Million
Reify Health Inc. has raised a $220 million venture-capital round at a $2.2 billion valuation to grow a business that uses technology and services to speed patient enrollment in clinical trials.
The coronavirus pandemic, and efforts to make clinical research more diverse, has spurred drugmakers to consider new methods of conducting clinical studies. They include decentralized trials, which enable patients to participate in studies from home or other locations outside a hospital. That in turn has encouraged investor interest...
Gloss